Ironwood Pharmaceuticals
IRWD
IRWD
193 hedge funds and large institutions have $1.8B invested in Ironwood Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 64 increasing their positions, 69 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
-2
Holders Change %
-1.03%
% of All Funds
4.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
64
Reduced
69
Closed
29
Calls
$6.98M
Puts
$1.02M
Net Calls
+$5.96M
Net Calls Change
+$3.57M
Top Buyers
| 1 |
SCM
Sarissa Capital Management
Greenwich,
Connecticut
|
+$32.5M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
+$23.7M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$18.3M |
| 4 |
BM
Bridger Management
New York
|
+$15.6M |
| 5 |
SPC
Slate Path Capital
New York
|
+$13.5M |
Top Sellers
| 1 |
MP
MFN Partners
Boston,
Massachusetts
|
-$31M |
| 2 |
Two Sigma Investments
New York
|
-$12.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$10.8M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.2M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$9.24M |
